Suchergebnisse - "Zenz, Thorsten"

PubPharm (4)

1

IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

enthalten in: Blood advances | 2023

von Syrykh, C. | Pons-Brun, B. | Russiñol, N. | +27

CommentIn: Blood Adv. 2023 Dec 12;7(23):7382-7383. - PMID 38085552

2

Comparing the value of mono- vs coculture for high-throughput compound screening in hematological malignancies

enthalten in: Blood advances | 2023

von Herbst, S. | Kim, V. | Roider, T. | +11

3

Comparing the value of mono- vs coculture for high-throughput compound screening in hematological malignancies

enthalten in: Blood advances | October 10, 2023

von Herbst, S. | Kim, V. | Roider, T. | +11

4

A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression

enthalten in: Blood advances | 2022

von Abrisqueta, P. | Medina, D. | Villacampa, G. | +12

1
[1]